This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing the treatment landscape for peanut allergies, including RAPT's long acting ozureprubart, OIT, Xolair and SLIT, as well as DBVT's Viaskin Peanut studies.
Ticker(s): RAPT, NVS, DBVTWho's the expert?
Institution: Institute For Asthma & Allergy
- Director of the Center for Urticaria and Angioedema at the Institute For Asthma & Allergy.
- Manages 200 pateints for peanut allergies
- Also maintains a part-time faculty position at the Johns Hopkins.
Interview GoalThis conversation will focus on the treatment landscape and potential use of RAPT's long acting ozureprubart, OIT, Xolair and SLIT, as well as DBVT's Viaskin Peanut studies.
Are You Interested In These Questions?
Slingshot Insights Explained
- Call Date
- Dec 04, 2025
- Call Time
- 09:00 AM EST
Wall Street Time
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
